Comparative efficacy of subcutaneous infliximab switching in remission and non-remission patients with inflammatory bowel disease after intravenous maintenance: 1-year outcome from a multicentre cohort study
Switching from IV to SC IFX during maintenance therapy demonstrated high treatment persistence and safety, irrespective of clinical and biochemical remission status.
Authors
- Dong-Hoon Yang (ORCID: https://orcid.org/0000-0003-1248-0438)
- Sang Hyoung Park (ORCID: https://orcid.org/0000-0002-5366-5749)
- Byung Ik Jang (ORCID: https://orcid.org/0000-0002-3037-9272)
- Eun Soo Kim (ORCID: https://orcid.org/0000-0003-0806-9136)
- Byong Duk Ye (ORCID: https://orcid.org/0000-0001-6647-6325)
- Hyeong Ho Jo (ORCID: https://orcid.org/0000-0002-4950-5435)
- Jung-Bin Park (ORCID: https://orcid.org/0000-0002-9031-7479)
- Sung Wook Hwang (ORCID: https://orcid.org/0000-0002-6981-7575)
- Seung-Jae Myung
- June Hwa Bae (ORCID: https://orcid.org/0000-0003-4117-822X)
- Eun Young Kim (ORCID: https://orcid.org/0000-0003-3525-8805)
- Yoo Jin Lee (ORCID: https://orcid.org/0000-0003-1799-0146)
- Ji Eun Baek (ORCID: https://orcid.org/0009-0008-5272-4293)
- Kyeong Ok Kim (ORCID: https://orcid.org/0000-0001-5799-7436)
- Suk‐Kyun Yang (ORCID: https://orcid.org/0000-0003-2772-2575)
- Seung Wook Hong
- Jeong‐Sik Byeon
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- Kyungpook National University (KR)
- Daegu Catholic University (KR)
- University of Ulsan (KR)
- Yeungnam University College
- Keimyung University (KR)
- Yeungnam University (KR)
Publication Details
- Journal
- Therapeutic Advances in Gastroenterology
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1177/17562848251333516
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63
Funders
- Asan Institute for Life Sciences, Asan Medical Center